Company ProfilePremium

Arrow Greentech Limited

Company Profile Analysis

Tickers: ARROWGREEN.NS, 516064.BO

ESOMAR 23 Corporate BadgeISO Certifications Badge
Arrow Greentech Limited - Company showcase

Year Founded & Workforce

1992

108 Employees

Arrow Greentech Limited logo

Arrow Greentech Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Arrow Greentech Limited Overview

Arrow Greentech is a promoter-controlled, IP-led Indian specialty-materials micro-to-small-cap that operates two economically distinct engines under one roof. Its High-Tech Products segment — anti-counterfeit security films, threads, fibres, laminates and related intellectual-property income, largely sold to high-security paper mills and document/brand-protection customers, partly through a Netherlands subsidiary — generated roughly 82% of FY26 revenue and nearly all of the swing in earnings. Its Green Products segment, built on the Watersol® brand, makes the company India's largest manufacturer of cast polyvinyl-alcohol (PVA/PVOH) water-soluble films for agrochemical, detergent, construction-chemical, embroidery and healthcare packaging, plus bio-compostable films; it grew 52% in FY26 to INR 369 Mn. A third, still loss-making option is Avery Pharmaceuticals' mouth-dissolving strip platform. The business is effectively debt-free, carries ~INR 1,294 Mn of cash and investments, earns 30–40% EBITDA margins in strong quarters, and exhibits pronounced order-driven volatility.


Company's own description

In its FY26 Annual Report, management frames Arrow Greentech as an innovation-and-IP franchise — the Chairman's letter characterises innovation as the company's "identity" and describes patents as its deepest moat. The company describes itself as "India's largest manufacturer of water-soluble films, marketed under our Watersol® brand", with a widening basket of bio-compostable solutions, alongside a High-Tech and Security business that manufactures anti-counterfeit products, security elements and security films for document, brand and high-security applications [AR26]. Its investor materials enumerate five business lines: Water Soluble Films, Intellectual Property, Security Products, Avery Pharma, and Other (Watersol Capsules and BioPlast) [IP-Aug26].

Morningstar's business description (derived from filings) states that the operating segments are Green Products (Water Soluble Films, Bio-Compostable Products, other green products) and Hightech Products (Anti-Counterfeit Products, IPRs and other high-tech products), with the Hightech segment generating the majority of revenue [Morningstar].

Business model and revenue model

Revenue streamNatureSegmentApprox. FY26 weightComment
Security films, threads, fibres, laminates, brand-protection elementsProduct sales (B2B, order/tender-driven)High-TechMajority of ~INR 1,636 MnLumpy; customer-order timing and procurement cycles drive quarterly swings [AR26]
Patent out-licensing, know-how transfer, IP incomeLicensing / royaltyHigh-Tech—Company states it monetises key patents through out-licensing and production of patented products [IP-May26]
Trading of raw materials for security productsTraded goodsHigh-Tech—"Purchase of stock in trade" was INR 339 Mn in both FY25 and FY26, indicating a material traded component [IP-May26]; company states it deals in supply of various raw materials [IP-Aug26]
Watersol® PVA water-soluble filmsProduct sales (B2B industrial)GreenMajority of INR 369 MnAgrochemical, detergent unit-dose, embroidery, construction chemicals, laundry bags, mould release
Bio-compostable films (BioPlast) and Watersol CapsulesProduct salesGreenSmallSingle-use plastic substitution
Mouth Dissolving Strips (MDS) — nutraceutical and Rx; CDMOProduct sales and contract development/manufacturingReported within group; Avery turnover INR 37.0 Mn in FY26~2%Loss-making subsidiary [AR26 AOC-1]

The mix is therefore predominantly product sales, with a licensing/IP overlay that is disclosed qualitatively but not quantified separately in the documents reviewed. There is no subscription revenue.

Value-chain position

Arrow sits in the middle of two specialty value chains. In water-soluble films it buys PVA resin and additives and performs batching, casting, slitting, curing, embossing, printing and packing [IP-Aug26] — converting a commodity polymer into a performance film sold to formulators and packagers (agrochemical and detergent companies, embroidery converters). In security products it supplies engineered security elements into high-security paper mills and document/brand-protection converters, making it a Tier-2 supplier upstream of security printers. It describes itself as "part of the niche group supplying such products globally", with "100% indigenous technologies" [IP-Aug26].

Customers and end-markets

End-marketProductsCustomer typeDisclosure status
High-security paper (currency/cheque/passport-grade papers)Security threads, multicolour fibres/planchettes, colour-shift filmsPaper mills, security printersCompany says it is a "supplier to leading paper mills"; customer names not disclosed [IP-Aug26]
Document and brand protectionSecurity laminates, self-destructive security packaging film, labelsBrand owners, converters, document issuersCustomers not disclosed
AgrochemicalsAgrochemical packaging WSFAgrochemical formulators (India, Brazil)Q1 FY26 commentary noted increased exports to Brazil and negligible exports to the USA [ScanX]
Home & laundry careDetergent (AD) film, toilet-block film, Watersol CapsulesFMCG / private-label—
TextilesEmbroidery backing filmEmbroidery units—
Construction chemicals, dyes & pigmentsPackaging filmChemical companies—
HealthcareWater-soluble laundry bags for contaminated linen; MDSHospitals; pharma/nutraceutical brand owners (CDMO)Avery states a long-term contract signed with a "big MNC company for export markets" (counterparty undisclosed) [IP-May26]

Independent characterisation

Arrow Greentech is best understood as a small security-materials company with a green-packaging hedge rather than the reverse. On FY26 numbers, High-Tech produced ~82% of revenue and, given the margin profile (the consolidated EBITDA margin moves from ~25% to ~41% as High-Tech revenue swings, per Q4 FY26 vs Q1 FY27 [IP-May26; IP-Aug26]), an even larger share of profit. The segment's customer concentration, procurement-driven order timing and the Netherlands subsidiary's outsized contribution (Advance Secure Products B.V. turnover INR 396 Mn and PAT INR 78 Mn in FY26 [AR26 AOC-1]) imply limited earnings visibility. The Green segment is structurally attractive (plastic-substitution tailwinds, India leadership) but at INR 369 Mn is too small to anchor valuation. The patent estate is real and growing, but direct licensing income is not quantified, so the "IP moat" thesis is evidenced more by grants than by disclosed monetisation.

Strategy

Stated strategy (themes from FY26 Annual Report and investor materials)

The Chairman's FY26 letter sets out four explicit priorities for FY27 and beyond [AR26]:

  1. Scale the Green Products business through new capacity (Dahej-II) and new applications, positioned against "a structural and irreversible global shift toward sustainable packaging".

  2. Convert the IP pipeline into "the next generation of security solutions and related business verticals".

  3. Grow Avery toward regulated markets through partnerships and approvals.

  4. Expand the international footprint via the UK and Netherlands subsidiaries.

Cross-cutting themes: Make in India / Atma-Nirbhar Bharat alignment (import substitution in security materials and conservation of foreign exchange), a "fortress balance sheet", disciplined capital allocation, and continued R&D investment [AR26]. The FY26 results commentary added a High-Tech "recalibration" agenda to realign with evolving customer demand and geopolitical factors, plus cost discipline and mix shift to "higher-value, differentiated offerings" [IP-May26].

Initiative register (last 24 months)

InitiativeDateDescriptionStatus / targetSource
Dahej-II Greentech capacityLand Sept 2023; ongoing~3-acre GIDC plot for WSF/green expansion; phase 1 targeted in ~18 monthsNot confirmed complete as of FY26 AR; capex spend lowBSE 15 Sep 2023; [AR26]
ESOP Scheme 2024Approved 16 Sep 2024Up to 225,000 options to attract/retain talentGrants not disclosed[AR26]
Patent expansion programme2025–2026Grants in US, Europe, India, Sri Lanka, Malaysia, Singapore for colour-shift films, security laminates, fibres, graphene thread24 in-force patents (May 2026); 10+ Indian and 3 foreign applications pending[IP-May26]; exchange filings
Avery regulated-market push2025–2026Product registrations in Russia, Yemen, Vietnam; CDMO projects; long-term MNC export contractRevenue INR 37 Mn FY26; loss continuing[IP-May26]; [AR26]
High-Tech recalibrationFrom Q4 FY26Re-engagement with customers, mix shift, procurement participationQ1 FY27 High-Tech revenue +137% YoY[IP-May26]; [IP-Aug26]
Green export diversificationFY26Increased exports to Brazil; US de-emphasisedForex earnings +118% FY26[ScanX]; [AR26]
Investor outreach2025–2026Regular quarterly presentations; MUFG Intime as IR adviser; analyst meets (e.g. 15 Jun 2026)OngoingScanX; [IP-Aug26]
Auditor rotationSept 2026KNAV & Co. LLP replaces Haribhakti & Co. LLPEffective FY27[AR26]

ESG commitments

No quantified emissions, energy or circularity targets were identified. The company's environmental positioning rests on its product portfolio (PVA water-soluble and compostable films displacing conventional plastics) and FIPSA 2026 recognition [AR26].

Guidance and medium-term targets

Management does not provide quantitative revenue, margin or capex guidance. Q1 FY27 commentary expresses "confidence" for the balance of FY27 without numbers [IP-Aug26]. No medium-term financial targets disclosed.

Products & Services

Green Products — Watersol® water-soluble films (WSF)

ProductDescription / applicationTarget customerNotes
AD Film (detergent packaging film)Unit-dose pouches for powder/liquid detergents, dishwashFMCG, private labelFlagship consumer-goods application
Agrochemical packaging filmPre-measured pesticide/fertiliser packs reducing handler exposureAgrochemical formulatorsExports to Brazil increased in Q1 FY26 [ScanX]
Dyes & pigments packaging filmDust-free dosing of dyes/pigmentsChemical/dye houses—
Construction chemical & fibre packagingDissolvable packs for admixtures/fibres added to concreteConstruction-chemical companies—
Toilet-block packaging filmWrapping for toilet blocksHome-care—
Water-soluble laundry bagPVOH bags for hygienic handling of contaminated hospital linenHospitals, healthcare laundries—
Mould-release filmRelease film in mouldingComposites/industrial—
Embroidery filmWater-soluble backing removed after embroideryTextile/embroidery units—
Seed bomb / seed tape packagingDissolvable seed carriersHorticulture—
Cold Water Soluble FilmPatented variant (India grant 20 Feb 2024)Packaging[IP-May26]
Improved Water Soluble FilmPatented (India grant 12 Dec 2023)Packaging[IP-May26]
Edible water-soluble packaging filmPatented (India grant 5 Jun 2012)Food[IP-May26]
Historic variantsWater-transfer printing film, soap film ("Arrow Magic Strips"), fish-bait film, enzyme film, battery separator, dust-protection filmVariousListed in 2019–2023 presentations; current commercial status not confirmed

The core technology is a flexible PVA/PVOH film that dissolves fully in water without residue; capability claims include tensile strength to handle 10 g–10 kg loads, moisture/heat sealing, accurate dosing, optimum tear and puncture resistance, organic-solvent resistance, machine-automation compatibility, anti-static and odourless properties [IP-Aug26]. Pricing: not publicly disclosed.

Green Products — other

ProductDescriptionStatus
BioPlast (bio-compostable film)Compostable alternative to single-use plastic; supported by Indian patent "Bio-Compostable Multi-Layered Composite" (grant 10 Jan 2024)Commercial; revenue not separately disclosed [IP-Aug26; BSE filing 6 Feb 2024]
Watersol Capsules (formerly marketed as KlenzPro)Highly concentrated hygiene/cleaning products in water-soluble capsules, no plastic wasteCommercial; scale not disclosed [IP-Aug26; Nov 2023 presentation]

High-Tech Products — security and anti-counterfeit

Product / technologyDescriptionProtectionTarget customer
Security threads for high-security paperAnti-counterfeit threads embedded in security papers (cheques, banknote-grade, passport papers)Process know-how; "Security Yarn" patent (India, 8 Sep 2023)Security paper mills
Multicolour security fibres / planchettesColoured fibres/planchettes embedded in high-security paperIndian Patent No. 580835 (granted 17 Feb 2026)Paper mills
Colour Shift Base FilmBase film exhibiting colour shiftIndian Patent No. 589622 (granted 2026; term from 18 Mar 2021)Security printers, film converters
Dual-Colour Shift Security FilmDocument security via dual colour-shift effectUS Pat. 12194771 (14 Jan 2025); Europe (30 Apr 2026); India (announced 12 Aug 2026)Document issuers, security printers
Graphene-based security threadNext-generation threadIndia grant (20 Jun 2026 per [IP-Aug26])Paper mills
Security laminates to secure documentsLaminates incorporating security elementsUK (24 Jan 2024), Sri Lanka (5 Jun 2025), Malaysia MY-211221-A (19 Nov 2025), Singapore 11202252919H (31 Aug 2026)ID/document issuers
Self-destructive irreversible security packaging filmTamper-evident packagingUS (23 Aug 2016; divisional 7 Dec 2021)Brand owners
High-security film (method and product)Security film manufacturing processEurope (15 Aug 2012)Converters
High-strength paperPaper and processUS (22 Nov 2011); Europe (5 May 2010)Paper/packaging
Raw-material supplyTrading of raw materials to security customers—Paper mills/converters

Intellectual-property services

Out-licensing, know-how transfer and technology partnerships managed by the Mumbai IP cell [AR26; IP-Aug26]. Licensees, royalty rates and IP revenue: not publicly disclosed.

Printing and self-adhesive (PSA) materials (patent-backed)

TechnologyGrantApplication
New improved self-adhesive materials with water-soluble filmsIndia, 30 Oct 2023Labels
Self-adhesive materials with water-soluble protective layerUS, 9 Nov 2010Labels
Self-adhesive wallpaper with reduced adhesive and WSFIndia, 16 Mar 2023Wallcoverings, hoardings

Health & hygiene technologies (patent-backed)

TechnologyGrantApplication
Medicated bandsIndia, 13 May 2024Healthcare
WSF-based matrix to contain samples from living speciesEurope 24 Jul 2013; USA 18 Mar 2014Bio-sample collection/disposal ("RX Matrix")
Cleaning device with sustained release of activesIndia, 1 Feb 2023Hygiene
Active-embedded water-soluble filmGranted (jurisdiction per Avery materials)Basis of MDS platform

Avery Pharmaceuticals — Arrow RX mouth-dissolving strips (MDS)

CategoryNamed products (selection, verbatim from company lists)
Nutraceutical MDS (FSSAI)Vitamin B12; Vitamin D3; D3+K2; D3+K2+Calcium; Folic Acid; L-Methyl Folate; B-Complex; B3; Vitamin C; C+Zinc; C+Zinc+D3; K2; Iron; Zinc Picolinate; Lactoferrin; Ashwagandha; Curcumin; Curcumin+Piperine; Astaxanthin; Lutein+Zeaxanthin; Clove Oil; Hemp; Echinacea+Propolis; L-Arginine+Caffeine; Caffeine combinations; Melatonin (incl. "Sleep MX" brand) and combinations; Millet+Vitamins; Bacillus Coagulans+FOS; Probiotics; Immune Booster; Multivitamin complex; mouth-freshener films; food-grade edible film; Hangover MDS
Rx — WHO-GMP productsNicotine Polacrilex MDS (1/2/4 mg); Ondansetron MDS (4/8 mg); Sildenafil MDS (25/50 mg)
Rx — licensed for domestic & exportAmlodipine MDS; Tadalafil ODS; Vitamin D3 MDS (2,000/60,000 IU); Vitamin B12 MDS; "NOS Primes Spiced Rose" 2 mg
Rx — test licence (pipeline)Clonazepam, Dextromethorphan, Donepezil, Eliglustat sublingual film, Ketorolac, Levocetirizine, Levocetirizine+Montelukast, Montelukast, Paracetamol, Rizatriptan, Simethicone, Voglibose, Zolmitriptan ODS
PlatformsMDS films (NDDS), Novel Drug Delivery Device (controlled release), RX Matrix (bio-sample collection)

Facility: WHO-GMP, FSSAI, GLP, ISO 9001 and ISO 22000 certified plant with in-house product development centre at Sanand, Gujarat. Portfolio: 54+ FSSAI-approved nutraceutical products and 10+ Rx-approved products; registrations being pursued in Russia, Yemen and Vietnam; CDMO projects; long-term export supply contract with an unnamed MNC [IP-May26; IP-Aug26].

Commercial scale: Avery turnover INR 37.0 Mn in FY26 (FY25: INR 18.1 Mn) with losses of INR 36.1 Mn (FY25: INR 47.4 Mn) [AR26 AOC-1]. Pricing: not disclosed.

Financial Narrative

Income statement: notes and sources

Sources: Revenue, EBITDA, PAT from [IP-May26] five-year chart; gross profit FY22–FY24 from [SA], FY25–FY26 from [IP-May26] (FY25 gross profit shown as INR 1,304 Mn by [SA] vs INR 1,313 Mn by the company — discrepancy noted; company figure used); operating income from [SA]; other income approximated from [SCR] in crore for FY22–FY24 and [IP-May26] for FY25–FY26; EPS from [AR26] (Screener shows FY23 consolidated EPS INR 8.14 vs AR INR 8.52 — discrepancy noted); DPS from [AR26], [PR-Q4FY25], Upstox corporate actions. Diluted EPS: not separately disclosed in reviewed materials (no dilutive instruments outstanding identified other than ESOP 2024 authorisation; diluted ≈ basic).

Margins and growth (consolidated)

Revenue CAGR FY22–FY26 (4-year): ~56% (base effect from trough FY22). Revenue CAGR FY23–FY26 (3-year): ~22.6%. Five-year sales CAGR per Screener (FY21 base): 31% consolidated [SCR]. PAT margins as presented by the company on revenue from operations are -26%/11%/19%/25%/23% (FY22–FY26), slightly different from the computed figures above due to the treatment of PAT attributable vs total [IP-May26].

Quarterly P&L — last five quarters

Sources: [IP-Aug26], [IP-May26], [IP-Jun25]; Q2 FY26 derived as FY26 total minus Q1, Q3, Q4; Q2 EPS from [SCR]. Trailing-twelve-month (Q2 FY26–Q1 FY27): revenue ~INR 2,468 Mn, EBITDA ~INR 862 Mn, PAT ~INR 639 Mn (≈ Screener TTM INR 247 Cr revenue / INR 63.9 Cr profit).

Q1 FY27 deep-dive. Revenue rose 110% QoQ and 111% YoY to INR 878 Mn; gross margin held at 54.7% (vs 55.5% in Q4 FY26), so the EBITDA margin expansion to 40.9% came from operating leverage — employee expense was flat at INR 47 Mn and other expenses fell to INR 75 Mn [IP-Aug26]. Management called it "a defining quarter" reflecting "commercial conversion of several years of investment" [IP-Aug26]. This single quarter delivered 58% of FY26's full-year PAT.

Balance sheet (consolidated)

Sources: FY25–FY26 from [IP-May26] consolidated balance sheet; FY22–FY24 totals, equity and borrowings from [SCR] (crore × 10); FY24 opening cash INR 76 Mn from [IP-May26] cash-flow statement. Zero values for FY22–FY24 in line-items denote not disclosed in the materials reviewed, not actual zeros. Zerodha reports net debt of INR -45.8 Cr (Mar-25) and INR -53 Cr (Mar-26), apparently counting only cash and bank balances — a definitional discrepancy versus the INR -127 Cr computed here including current investments.

Commentary. The balance sheet is the company's strongest feature. Equity more than tripled from ~INR 750 Mn (FY22) to INR 2,362 Mn (FY26), driven entirely by retained earnings; no equity has been issued since the March 2020 rights issue [AR26]. At March 2026, liquid assets of ~INR 1,294 Mn represented 51% of total assets and ~55% of equity. Current ratio rose from 10.3x (FY25) to 13.7x (FY26). The flip side is capital efficiency: a growing cash pile dilutes ROE (from ~40% in FY25 to ~22% in FY26) and has not yet been deployed into the Dahej expansion at scale.

Cash flow (consolidated)

Sources: FY25–FY26 from [IP-May26]; FY22–FY24 and FCF/capex from [SCR] (rounded crore). Dividends paid derived: FY24 pays FY23 DPS ~INR 1, FY25 pays FY24 INR 2, FY26 pays FY25 INR 4 (× 15.09 Mn shares). No buyback has been undertaken in the audit period [AR26 Secretarial Audit].

Commentary. Cash conversion has improved sharply: CFO/EBITDA was ~103% in FY25 and ~94% in FY26 (Screener basis) versus 25% in FY23 [SCR]. FY26 CFO fell to INR 431 Mn as working capital absorbed INR 94 Mn (inventories +INR 51 Mn, receivables +INR 49 Mn) [IP-May26]. Investing outflows are dominated by treasury deployment into current investments rather than capex; capex has run at only INR 40–100 Mn a year, which is inconsistent with a meaningful Dahej build-out to date.

Ratio analysis

Sources: ROE/ROCE from [IP-May26] five-year chart (decoded as ROE -12/14/26/40/22 and ROCE -12/21/36/54/31, consistent with Screener ROCE of -12/21/35/53/30); other ratios computed by analyst from figures above; CCC/debtor/inventory days from [SCR]. ROIC is an analyst derivation (EBIT ex-OI × (1 − 27% tax) ÷ (total equity − net cash)) and should be treated as indicative. Zero placeholders mean not computed due to missing inputs.

Trend commentary. Three inflections stand out. (1) FY23 turnaround: the business moved from an EBITDA loss to a 22% margin on a tripling of revenue, consistent with the High-Tech segment's ramp. (2) FY25 peak: operating leverage took EBITDA margin to 36% and ROCE to 54%. (3) FY26 normalisation: revenue fell 18% but gross margin actually improved (54.5% vs 54.0%), showing the decline was volume/mix-driven at the High-Tech level rather than price erosion; EBITDA margin contracted 410 bps on fixed-cost deleverage. The working-capital cycle is structurally long (100+ days in most years), reflecting inventory-heavy specialty manufacturing and order-based billing.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityCountryAGL stakeRoleFY26 turnover (INR Lakh)FY26 PAT (INR Lakh)Source

Arrow Greentech Ltd (parent)

India

—

WSF manufacturing (Ankleshwar), security products, IP cell

16,470 (standalone total income)

4,249

[AR26]

Arrow Green Technologies (UK) Ltd

UK

100%

International holding/business development

318177

[AR26 AOC-1]

Advance IP Technologies Ltd

UK

95% (via UK sub)

IP / technology

33634

[AR26 AOC-1]

Advance Secure Products B.V.

Netherlands

100% (via UK sub)

Security products trading/supply into Europe

3,962778

[AR26 AOC-1]

Avery Pharmaceuticals Pvt Ltd

India

99.65% (described as WOS)

Mouth-dissolving strips, CDMO (Sanand)

370(361)

[AR26 AOC-1]

LQ Arrow Security Products (India) Pvt Ltd

India

51%

Security products JV

588

[AR26 AOC-1]

Arrow Secure Technology Pvt Ltd

India

100%

Effectively dormant (nil turnover)

0(0)

[AR26 AOC-1]

SP Arrow Bio Polymer Products Pvt Ltd

India

46% (associate)

Bio-polymer; not consolidated (no control)

—(0)

[AR26 AOC-1]

Sphere Bio Polymer Pvt Ltd

India

Former associate

Strike-off applied 26 Mar 2025

——

[AR25 AOC-1 as reproduced in AR26]

Segment Overview

SegmentContents (per filings)Key products

Hightech Products

Anti-counterfeit products, IPRs, other high-tech products

Security threads, multicolour security fibres/planchettes, colour-shift and dual-colour-shift security films, security laminates, self-destructive security packaging film, graphene-based security thread, brand-protection elements, patent licensing

Green Products

Water-soluble films, bio-compostable products, other green products

Watersol® WSF range, BioPlast compostable film, Watersol Capsules

Revenue by Segment and Revenue by Segment (%)

SegmentFY2024FY2025FY2026

Hightech Products revenue (INR Mn; FY24 derived)

1,2242,1911,636

Green Products revenue (INR Mn; FY24 derived)

261243369

Total revenue from operations (INR Mn)

1,4852,4342,005

Hightech share of revenue (%)

82.490.081.6

Green share of revenue (%)

17.610.018.4

Hightech YoY growth (%)

079-25.3

Green YoY growth (%)

0-6.951.9

Revenue by Segment

SegmentQ1FY26Q2FY26Q3FY26Q4FY26Q1FY27

Hightech Products revenue (INR Mn; Q2 derived)

344488458346816

Green Products revenue (INR Mn)

721231037163

Total revenue from operations (INR Mn)

416611561418878

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Income Statement and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Revenue from operations (INR Mn)

3371,0881,4852,4342,005

Revenue growth YoY (%)

-35.7223.136.563.9-17.6

Gross profit (INR Mn)

1375398901,3131,093

EBITDA (INR Mn, company-defined, excl. other income)

-73235463884646

Operating income / EBIT excl. other income (INR Mn)

-100188394817568

Other income (INR Mn)

2020305385

Finance cost (INR Mn)

68224

Pre-tax income (INR Mn)

-110180407860650

Net income / PAT (INR Mn)

-93123293630474

EPS basic (INR)

-6.628.5219.5641.8331.38

Dividend per share (INR; FY23 derived from ~12% payout)

01245

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Gross margin (%)

40.749.559.954.054.5

EBITDA margin (%)

-21.721.631.236.332.2

Operating (EBIT ex-OI) margin (%)

-29.617.326.633.628.3

PAT margin (%)

-27.611.319.725.923.6

Income Statement and Margin Analysis (%) (Quarterly)

MetricQ1FY26Q2FY26Q3FY26Q4FY26Q1FY27

Revenue from operations (INR Mn)

416611561418878

Gross profit (INR Mn; Q2 not disclosed, shown as 0)

2370304232480

EBITDA (INR Mn; Q2 derived)

143207192104359

EBITDA margin (%)

34.333.934.324.840.9

PBT (INR Mn; Q2 derived)

143208193106363

PAT (INR Mn; Q2 derived)

10915813374274

EPS (INR)

7.2110.438.814.9018.15

Balance Sheet

MetricFY2022FY2023FY2024FY2025FY2026

Total assets (INR Mn)

8901,2101,4502,0842,558

Total equity incl. NCI (INR Mn; FY22–FY24 from Screener crore)

7509801,2701,9002,362

Borrowings (INR Mn; FY25–FY26 = lease liabilities)

503010723

Cash & cash equivalents (INR Mn)

0076167268

Other bank balances (INR Mn)

000291262

Current investments (INR Mn)

000454764

Gross cash & liquid investments (INR Mn)

0009121,294

Net debt (INR Mn; negative = net cash; Zerodha figures for FY25/FY26 basis differ)

000-905-1,271

Goodwill & intangibles incl. under development (INR Mn)

0002621

Inventories (INR Mn)

000202253

Trade receivables (INR Mn)

000293342

Net working capital incl. cash (INR Mn)

0001,3781,842

Cash Flow

MetricFY2022FY2023FY2024FY2025FY2026

Operating cash flow (INR Mn; FY22–FY24 from Screener crore)

2030180676431

Capex (INR Mn; derived CFO minus FCF from Screener)

80401007040

Free cash flow (INR Mn)

-60-1080610390

Investing cash flow (INR Mn)

-20-140-140-546-259

Financing cash flow (INR Mn)

-2080-40-39-71

Dividends paid (INR Mn; derived from prior-year DPS × shares)

00153060

Buybacks (INR Mn)

00000

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2022FY2023FY2024FY2025FY2026

ROE (%, company-reported)

-1214264022

ROCE (%, company-reported)

-1221365431

ROA (%, PAT / average total assets)

-1012223620

ROIC (%, derived NOPAT / equity less net cash; FY25–FY26 only)

0006139

Current ratio (x; FY25–FY26 only)

00010.313.7

Debt to equity (x)

0.070.030.010.000.01

Net debt to EBITDA (x; FY25–FY26)

000-1.0-2.0

Interest coverage (EBIT incl. OI / finance cost, x)

-1526212431163

Asset turnover (x, revenue / average assets)

0.361.041.121.370.86

Cash conversion cycle (days, Screener consolidated)

10612118781141

Debtor days (Screener consolidated)

4088794462

Inventory days (Screener consolidated)

12710113866101

Revenue by Region

MetricFY2025FY2026

Standalone foreign-exchange earnings (INR Mn)

61.0133.1

Standalone foreign-exchange outgo (INR Mn)

146.1180.9

Advance Secure Products B.V. (Netherlands) turnover (INR Mn)

363.3396.2

Arrow Green Technologies (UK) turnover (INR Mn)

51.331.8

Advance IP Technologies (UK) turnover (INR Mn)

033.6

Consolidated minus standalone revenue from operations (INR Mn)

374358

Valuation Snapshot

MetricValueSource

Price (19 Oct 2026, intraday)

INR 776

[SCR]

Price (16 Oct 2026, close)

INR 806

[SCR]

52-week high / low

INR 953 / INR 342

[SCR]

Lifetime high / low

INR 1,099 / INR 30.30

Anand Rathi

1-year return

+46%

[SCR]

YTD 2026 (to 8 Oct 2026)

+67.6%

MarketScreener

3-year price CAGR

23%

[SCR]

5-year price CAGR

46–48%

[SCR]

10-year price CAGR

7%

[SCR]

Metric

2,0242,025

Representative share price (INR; 21 Nov 2024, 13 Jun 2025, 16 Oct 2026)

907607

Valuation Multiples

MultipleArrow GreentechPeers

Market cap (INR Cr)

~1,171

Indian film peer median market cap ~INR 3,003 Cr (Zerodha)

Enterprise value (INR Cr)

~1,044 (mkt cap − INR 129 Cr liquid assets + INR 2 Cr leases)

—

P/E (TTM, EPS INR 42.30)

~18.3x (Screener shows 19.0–19.7x)

Value Research peer median 18.7x (Jun 2026)

EV/EBITDA (TTM EBITDA ~INR 86 Cr)

~12.1x

—

EV/Sales (TTM revenue ~INR 247 Cr)

~4.2x

—

P/B (book value INR 155)

~5.0x

Value Research peer median 1.3x (Jun 2026)

Dividend yield (INR 5)

~0.64%

—

Per-Share Data and Returns & Leverage Ratios (%)

MetricFY2022FY2023FY2024FY2025FY2026

DPS (INR; FY23 derived)

01245

Consolidated payout (%)

012101016

Capital Markets

ItemStatus

Buyback authorisations

None during audit period [AR26]

Equity issuance

None since March 2020 rights issue; ESOP 2024 authorised (225,000 options)

Debt maturity profile

Not applicable — no borrowings other than INR 23 Mn lease liabilities (INR 7 Mn current, INR 16 Mn non-current) at 31 Mar 2026 [IP-May26]

Analyst consensus

No sell-side coverage or consensus estimates identified

Analyst Conclusions

Management guidance

No quantitative guidance. Management expresses confidence for the remainder of FY27 following Q1, prioritising product-portfolio development and sustainable innovations [IP-Aug26], and lists four strategic priorities (Green capacity, IP conversion, Avery regulated markets, international expansion) [AR26].

Consensus expectations

No published consensus. Screener's automated flag that the company "is expected to give good quarter" is a machine-generated signal, not an estimate [SCR].

Bull case

  1. Earnings power re-established: Q1 FY27 PAT of INR 274 Mn alone is 58% of FY26 PAT; even modest follow-through could put FY27 PAT above the FY25 record of INR 630 Mn.

  2. Cash-adjusted valuation is undemanding: with ~11% of market cap in liquid assets, the core business trades at ~12x TTM EV/EBITDA despite 30–40% EBITDA margins and a 24-patent estate.

  3. Green optionality: a segment that grew 52% in FY26 in a 5.8%-CAGR global market, with export momentum (forex earnings +118%) and a land bank for expansion.

Bear case

  1. Lumpiness is structural: FY26 showed High-Tech can fall 25% with little warning; one strong quarter does not establish a run-rate, and no customer concentration data is provided.

  2. Governance and capital allocation: material RPT with a promoter-family firm at ~21% of revenue in value, a 30% promoter pay rise after a down year, and a 16% payout despite surplus cash.

  3. Execution drag: Dahej-II capacity appears behind its original 18-month target; Avery continues to lose money; capex of only INR 40 Mn in FY26 is inconsistent with a scale-up narrative.

Catalysts and monitorables (next 12 months)

ItemExpected timingWhat to watch
Q2 FY27 results~Nov 2026 (trading window closed 30 Sep)Sustainability of High-Tech run-rate above INR 500 Mn/quarter; Green recovery
Q3 FY27 results~Feb 2027Working-capital normalisation (CCC <120 days)
Dahej-II commissioningUnconfirmedCapex step-up in cash flow; capacity disclosure
Avery breakevenFY27–FY28Revenue from MNC export contract; regulated-market approvals
Patent licensingOngoingFirst quantified IP/licensing revenue disclosure
Capital allocationFY27Use of ~INR 1.3 Bn cash: capex, dividend increase, buyback
RPT trajectory35th AGM (2027)ABS purchase values vs INR 70 Cr limit
Institutional ownershipQuarterlyDII creep (1.02% Sep 2026)
Auditor transitionFY27 audit by KNAVAny changes in accounting presentation

Analyst verdict

Arrow Greentech is a genuinely differentiated small-cap: an Indian company with a three-decade record of inventing and patenting functional films, a defensible domestic leadership in water-soluble PVA films, and a security-materials franchise that, when orders flow, produces margins most Indian specialty-chemical and packaging companies cannot match. The balance sheet is pristine — about INR 1.3 billion of liquidity, negligible debt, equity built entirely from retained earnings since 2020 — and cash conversion has improved materially since FY24.

The investment problem is predictability, not quality. Four-fifths of revenue comes from a High-Tech segment whose customers, contract structures and margins are not disclosed, and whose output swung from a 25% annual decline in FY26 to a 137% quarterly increase in Q1 FY27. A significant share of the international business runs through a Netherlands subsidiary that receives minimal narrative disclosure. The Green segment, while growing well, remains below a fifth of revenue and its capacity expansion appears delayed. Avery is an interesting technology platform but, at INR 37 million of revenue and continuing losses, is not yet a value driver.

Governance is acceptable but warrants monitoring: the company meets independence requirements and receives clean audit and secretarial reports, yet the material related-party supply arrangement with a promoter-family partnership, the combined Chair/MD role and a 30% pay rise for promoter-executives in a down year are legitimate minority-shareholder concerns. The September 2026 auditor rotation to KNAV is a neutral-to-positive procedural event.

At ~18x trailing earnings and ~12x EV/EBITDA, the stock prices in partial durability of the Q1 FY27 step-up. We would characterise it as a high-volatility, IP-rich, cash-rich special situation.


APPENDIX — SOURCES

[AR26]: Arrow Greentech Annual Report FY2025-26 incl. 34th AGM Notice (NSE filing, 26 Aug 2026) — https://nsearchives.nseindia.com/corporate/ARROWGREEN_26082026195520_AnnualReport26082026.pdf

[IP-Aug26]: Investor Presentation — Q1 FY27 (Aug 2026) — https://www.arrowgreentech.com/images/presentation/2026-27/AGTL%20Presentation%20Aug%202026.pdf

[IP-May26]: Investor Presentation — Q4 & FY26 (25 May 2026) — https://nsearchives.nseindia.com/corporate/ARROWGREEN_25052026134259_PresentationOnBusinessPerformanceOfTheCoMay2026.pdf

[IP-Jun25]: Investor Presentation — Q1 FY26 — https://www.arrowgreentech.com/images/presentation/2025-26/AGTL%20Investor%20Presentation%20Jun%202025.pdf

[PR-Q4FY25]: Press Release Q4/FY25 (17 May 2025) — https://nsearchives.nseindia.com/corporate/ARROWGREEN_17052025182428_Arrow_Greentech_Press_Release-Q4FY25.pdf

[PR-Q3FY26]: Press Release / Presentation Q3 FY26 (13 Feb 2026) — https://bsmedia.business-standard.com/_media/bs/data/announcements/bse/15022026/42220f68-9210-4374-bdb1-80d5931af8b6.pdf

[SCR]: Screener.in — consolidated and standalone financials, shareholding, announcements — https://www.screener.in/company/ARROWGREEN/consolidated/

[SA]: StockAnalysis.com income statement — https://stockanalysis.com/quote/nse/ARROWGREEN/financials/

BSE-Dahej: GIDC Dahej-II plot transfer intimation (15 Sep 2023) — https://bseindia.com/xml-data/corpfiling/AttachHis/339db135-7c94-4c22-b130-4c0ac36ea49a.pdf

BSE-Rights: Rights issue filings (3 Feb 2020; 19 Mar 2020) — https://bseindia.com/xml-data/corpfiling/AttachHis/03be1e47-1c5b-4734-94bb-cff29d1d1501.pdf

Patent filings: Malaysia (17 Feb 2026); India 580835 (23 Feb 2026); Sri Lanka (30 Jan 2026); bio-compostable (6 Feb 2024) — https://nsearchives.nseindia.com/corporate/ARROWGREEN_17022026123213_GrantOfPatent17022026.pdf ; https://nsearchives.nseindia.com/corporate/ARROWGREEN_23022026140835_GrantOfPatent23022026.pdf

Sahi: Singapore patent and Colour Shift Base Film coverage — https://www.sahi.com/news/arrow-greentech-granted-singapore-patent-for-secure-laminates-to-secure-documents

LegalSuvidha: Patent updates Jul/Aug 2026 — https://legalsuvidha.com/latest-updates/arrow-greentech-granted-patent-070726

ScanX: Q1/Q2 FY26 results, analyst meet, patent news — https://scanx.trade/stock-news/arrow-greentech-ltd

Multibagg: FY26 and Q1 FY27 analyses — https://www.multibagg.ai/market-pulse/articles/arrow-fy26-94908

Univest: Q1 FY27 results and price reaction — https://univest.in/blogs/arrow-greentech-q1-results-fy27-pat-27-crore

MarketScreener: Event calendar and price — https://www.marketscreener.com/quote/stock/ARROW-GREENTECH-LIMITED-23640775/calendar/

Morningstar: Business description; employees — https://morningstar.com.au/investments/security/NSE/ARROWGREEN

Zerodha: Peer set; net debt; dividends — https://zerodha.com/markets/stocks/BSE/ARROWGREEN/

Value Research: Peer multiples; 52-week range — https://www.valueresearchonline.com/stocks/41106/arrow-greentech-ltd/

Company history: IIFL, Arihant, Goodreturns, Sharekhan profiles — https://www.indiainfoline.com/company/arrow-greentech-ltd/summary ; https://www.goodreturns.in/company/arrow-greentech/history.html

FilingReader: FY25 and FY26 annual-report summaries — https://filingreader.com/news-wire/mumbai/2026-08-26/arrow-greentech-reports-inr-2005m-revenue-for-fy26

Derived figures are labelled as such.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameTitleAgeBoard tenureEducationBackgroundShares held (31 Mar 2026)

Shilpan P. Patel

Chairman & Managing Director (KMP, promoter)

70

Since 30 Oct 1992; current term 1 Apr 2025 – 31 Mar 2030 (special resolution passed for continuation past age 70)

MBA, Sam Houston State University (Texas); B.Com, H.L. College of Commerce, Ahmedabad

~9 years at Grace Paper Industries; inventor of Arrow's WSF (1990); leads business development, strategy and IP cell; named inventor on patents in USA, Europe, South Africa, Australia, India

52,39,557 (~34.7%)

Neil S. Patel

Joint Managing Director (KMP, promoter group)

40

Additional Director 1 Jun 2012; with company since 2009; current term from 1 Apr 2025

M.Sc. Biomedical Science, Kingston College, London

Operations leadership; Audit and Stakeholders' Relationship Committee member; director of Avery, UK subsidiaries

4,10,272 (~2.7%)

Jigisha S. Patel

Non-Executive, Non-Independent Woman Director (promoter group; wife of CMD)

69

Since 14 Jul 2020

B.A., Calcutta

Administration; partner in related party Advance Business Solutions

16,97,205 (~11.2%)

Prashant S. Mehta

Independent Director; Chair of Audit and NRC

72

Since 13 Feb 2024

B.Com (Narsee Monjee, 1976); LLB (New Law College, 1978); Company Secretary

40+ years legal/secretarial at Premier Ltd, JISCO (now JSW Steel), Shoppers Stop

—

Yogesh Gajjar

Independent Director; Chair of Stakeholders' Relationship Committee

73

Since 8 Feb 2025

Diploma in Electronics (Govt Polytechnic, 1975)

45 years in electricals/electronics services business, Ahmedabad

—

Barkharani H. Nevatia

Independent Woman Director

32

Since 13 Feb 2024

Chartered Accountant; LLB (Mumbai University); Narsee Monjee College

Practising CA (Pune/Mumbai): corporate tax, statutory audit, GST, income tax

—

Hitesh Punglia

Chief Financial Officer (KMP)

—————

Poonam Bansal

Company Secretary & Compliance Officer (KMP)

—

At least since 2020 (signed Jan 2020 rights filings)

———

“—” = not publicly disclosed.

Directors' Remuneration

ExecutiveFY26 salary basisRevised (w.e.f. 1 Jul 2026)OtherSource

Shilpan P. Patel (CMD)

INR 9.00 lakh/month (INR 1.08 Cr p.a.) + PF, gratuity, perquisites

INR 11.70 lakh/month (INR 1.404 Cr p.a.), +30%

Chauffeur-driven car, superannuation, reimbursements; capped within Section 197 limits (5% of net profit per executive director, 10% all EDs)

[AR26] Notice items 6

Neil S. Patel (JMD)

INR 9.00 lakh/month (INR 1.08 Cr p.a.)

INR 11.70 lakh/month (INR 1.404 Cr p.a.), +30%

Same structure

[AR26] Notice item 7

CFO, CS

Not disclosed in extracted text

———

Directors' Remuneration by Attribute

AttributeStatus

Board size

6

Independent directors

3 of 6 (50%) — meets SEBI LODR requirement for a board chaired by an executive promoter

Women directors

2 (Jigisha Patel, Barkharani Nevatia)

Chair/CEO separation

No — Shilpan Patel is both Chairman and MD

Promoter family on board

3 of 6

Audit Committee

Chair: Prashant Mehta; members: Yogesh Gajjar, Barkharani Nevatia, Neil Patel

Nomination & Remuneration Committee

Chair: Prashant Mehta; members: Yogesh Gajjar, Barkharani Nevatia

Stakeholders' Relationship Committee

Chair: Yogesh Gajjar; members: Neil Patel, Prashant Mehta

FY26 meetings

4 Board, 4 Audit Committee; separate Independent Directors' meeting 13 Feb 2026

Shareholding Trend

Holder categoryMar 2024Mar 2025Mar 2026Sep 2026

Promoters (%)

68.6064.8164.8365.65

FIIs (%)

1.280.270.060.08

DIIs (%)

0.000.040.821.02

Public (%)

30.1334.8834.2833.26

Number of shareholders

13,43022,60521,44220,500

Competitive Landscape

Competitors by Segment

SegmentCompetitorHQListing / ownershipRelative positioning vs Arrow

Water-soluble films

MonoSol (Kuraray Co.)

USA/Japan

Kuraray listed (Tokyo)

Global leader in PVOH films for unit-dose detergents; vastly larger scale and resin integration

Water-soluble films

Mitsubishi Chemical Group (Hi-Selon PVOH film)

Japan

Listed (Tokyo)

Integrated PVOH resin and film producer

Water-soluble films

Sekisui Chemical (PVOH films)

Japan

Listed (Tokyo)

PVOH specialty films/resins

Water-soluble films

Aicello Corporation (Solublon)

Japan

—

Specialist WSF producer

Water-soluble films

Chinese PVA film makers (e.g. Guangdong/Jiangmen-based producers)

China

Mostly private

Low-cost competition in commodity grades

Security threads/features

SICPA

Switzerland

Private

Global leader in security inks/authentication

Security threads/features

Crane NXT (Crane Currency)

USA

NYSE-listed

Leader in micro-optic security threads and banknote substrates

Security films/holograms

Leonhard Kurz

Germany

Private

Hot-stamping foils, optical security features

Security printing/features

Giesecke+Devrient

Germany

Private

Banknote and security features

Brand protection/holography (India)

Holostik India

India

Private

Domestic anti-counterfeit labels and holograms

Packaging films (Indian listed peers per Zerodha)

Uflex, Polyplex, Cosmo First, Jindal Poly Films, Xpro India, Nahar Poly Films

India

NSE/BSE listed

Commodity/specialty BOPET/BOPP film makers — size peers for valuation, not direct product competitors; Zerodha cites peer median market cap ~INR 3,003 Cr vs Arrow ~INR 1,091 Cr

Peer Comparison FY2026

MetricArrow Greentech (FY26)Arrow Greentech (TTM to Q1 FY27)

Revenue (INR Mn)

2,0052,468

Revenue growth (%)

-17.6

13 (Screener TTM)

EBITDA margin (%)

32.2

~35

PAT margin (%)

23.6

~26

ROE (%)

22

21 (Screener)

Company Snapshot

$23.2M

Revenue

108

Employees

1992

Founded

Mumbai, India

Headquarters

SWOT Analysis

Strengths

  • Net-cash fortress: ~INR 1,294 Mn cash, bank balances and current investments vs only INR 23 Mn lease liabilities at 31 Mar 2026 [IP-May26].
  • High margins: FY26 gross margin 54.5% and EBITDA margin 32.2%; Q1 FY27 EBITDA margin 40.9% [IP-May26; IP-Aug26].
  • Strong returns: 3-year average ROE ~28% (consolidated) [SCR]; FY25 ROCE 54% [IP-May26].
  • IP depth: 24 in-force patents (May 2026) and nine grants disclosed across six jurisdictions between Jan 2025 and Aug 2026 [IP-May26; exchange filings].
  • Category leadership: India's largest WSF manufacturer; FIPSA 2026 Commercial Innovation Award [AR26].
  • Cash conversion: CFO/EBITDA ~103% in FY25 and ~94% in FY26 [SCR].

Weaknesses

  • Revenue volatility: quarterly revenue ranged from INR 416 Mn to INR 878 Mn within five quarters [IP-Aug26].
  • Segment concentration: High-Tech 81.6% of FY26 revenue [IP-May26].
  • Disclosure gaps: no segment margins, customer concentration, R&D spend or geographic split in investor materials.
  • Related-party dependence: INR 41.7 Cr FY26 purchases from promoter-family partnership ABS, whose own turnover was INR 42.8 Cr with INR 8.1 Cr PAT on INR 5.2 Cr net worth — i.e. ABS appears to exist principally to supply Arrow [AR26].
  • Avery losses: INR 36.1 Mn loss in FY26, INR 47.4 Mn in FY25 [AR26 AOC-1].
  • Lengthening working capital: consolidated CCC rose from 81 days (FY25) to 141 days (FY26) [SCR].

Opportunities

  • Green capacity: Dahej-II plot (~3 acres) enables scale-up of a segment that grew 52% in FY26 [AR26].
  • Export markets: standalone forex earnings rose 118% to INR 133 Mn in FY26 [AR26]; Brazil agrochemical demand [ScanX].
  • IP monetisation: new colour-shift, graphene-thread and laminate patents can be licensed or productised [IP-Aug26].
  • Avery regulated markets: 10+ Rx approvals, 13 test-licence molecules, MNC export contract [IP-May26].
  • Capital deployment: idle cash (~55% of equity) could fund capex, M&A or higher payouts to lift ROE.
  • Index/institutional discovery: FII+DII ownership only ~1.1% (Sep 2026) [SCR].

Threats

  • Order-timing/geopolitics: management cited turbulent geopolitical events for FY26 High-Tech decline [IP-May26].
  • Global incumbents: Kuraray/MonoSol, Mitsubishi Chemical, SICPA, Crane NXT have far greater scale (not quantified here).
  • Raw-material cost: total raw material cost was 45.5% of FY26 revenue [IP-May26]; PVA price shocks would compress margins.
  • Key-person risk: CMD aged 70 is the principal inventor and IP-strategy leader [AR26].
  • Governance perception: 30% promoter pay rise in a year of 25% PAT decline; RPT with family firm [AR26].
  • Trade policy: US export negligible; tariffs could limit diversification [ScanX].

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
17 May 2025Q4/FY25 results: record revenue INR 2,434 Mn (+64%), PAT INR 630 Mn (+115%), INR 4 dividend; US dual-colour shift patent highlighted [PR-Q4FY25]Peak-year print; High-Tech +79%
~Jun 2025Annual Secretarial Compliance report (FY25) and patent-grant update filed Kotak Securities announcementsRoutine
Aug 2025Q1 FY26 results: revenue INR 416 Mn (-37% YoY), EBITDA margin 34.2%, PAT INR 109 Mn [IP-Jun25]Start of High-Tech softness
Aug 2025Management notes negligible US exports, higher Brazil exports for green products [ScanX]Geographic pivot
30 Aug 2025FY25 Annual Report released; Dahej-II land referenced for capacity FilingReaderStrategic intent
22 Sep 202533rd AGM: RPT approval (Advance Business Solutions, INR 70 Cr), secretarial auditor appointment, FY25 dividend [AR26]Governance
13 Nov 2025Q2 FY26 results: revenue INR 611 Mn (+47% QoQ), Green INR 123 Mn, PAT margin ~25% [ScanX]; MarketScreenerSequential rebound
19 Nov 2025Malaysia patent MY-211221-A granted (security laminates) NSE filing 17 Feb 2026IP expansion
30 Jan 2026Sri Lanka security-laminates patent announced BSE filing 30 Jan 2026IP expansion
13 Feb 2026Q3 FY26 results: revenue INR 561 Mn; Green +94% YoY to INR 103 Mn; High-Tech INR 458 Mn; PAT INR 133 Mn [PR-Q3FY26]Green momentum
13 Feb 2026Independent Directors' meeting [AR26]Governance
17 Feb 2026Malaysia patent disclosed to exchanges NSE filingIP
17/23 Feb 2026Indian Patent 580835 (multicolour security fibres) granted/announced NSE filing 23 Feb 2026IP
20 Feb & 5 Mar 2026Analyst/institutional investor meet intimations Arihant announcementsIR activity
4–27 Mar 2026Share price trough ~INR 387–394 (market cap ~INR 580–600 Cr) Upstox; Simply Wall StSentiment low ahead of FY26 results
30 Apr 2026European grant: dual-colour shift security film [IP-May26]IP
22 May 2026Q4/FY26 results: revenue INR 2,005 Mn (-17.6%), PAT INR 474 Mn (-24.8%); INR 5 dividend recommended; Green +52% [IP-May26]; Reuters via ZerodhaEarnings reset; dividend raised despite decline
25 May 2026Investor presentation cites High-Tech "recalibration" and geopolitical headwinds [IP-May26]Explains FY26 decline
28 May 2026FY26 Annual Secretarial Compliance Report — no material non-compliance [SCR]Governance clean
15 Jun 2026Analyst and institutional investor meet ScanXIR
~1–7 Jul 2026Indian Patent 589622 (Colour Shift Base Film) announced; promoters declare no encumbrance for FY26 LegalSuvidhaIP; governance
13 Aug 2026Q1 FY27 results: revenue INR 878 Mn (+111% YoY), EBITDA INR 359 Mn (40.9%), PAT INR 274 Mn (+151% YoY); stock closed INR 782.5 (-0.27%) [IP-Aug26]; UnivestRecord quarter; High-Tech INR 816 Mn
13 Aug 2026Board recommends KNAV & Co. as auditor, 30% pay revision for CMD/JMD, RPT renewal [AR26]Governance
12–13 Aug 2026Indian patent for dual-colour shift security film LegalSuvidha; SahiIP
26 Aug 2026FY26 Annual Report filed; 34th AGM notice NSE filingDisclosure
31 Aug 2026Singapore patent 11202252919H (security laminates) granted Sahi; BSE 21 Sep 2026IP
15 Sep 2026Record/ex-date for INR 5 FY26 dividend GrowwShareholder return
18 Sep 202634th AGM: KNAV appointment approved; other resolutions; results filed 21 Sep BSE filingsGovernance
30 Sep 2026Trading window closed ahead of Q2 FY27 results [SCR]Results due ~Nov 2026
8–19 Oct 2026Stock at INR 847 (8 Oct, +67.6% YTD), INR 806 (16 Oct), ~INR 776 (19 Oct) MarketScreener; [SCR]Re-rating post Q1 FY27

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Revenue by Segment (FY2024–FY2026): Total revenue from operations rose from INR 1,485 Mn in FY2024 to INR 2,005 Mn in FY2026.
Arrow Greentech Limited — Revenue by Segment (FY2024–FY2026)
Series (INR Mn)FY2024FY2025FY2026
Total revenue from operations1,4852,4342,005
Hightech Products revenue1,2242,1911,636
Green Products revenue261243369

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.